Prices are updated after-hours
Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
meeting   crawled date : 2021 - 04 - 10    save search
New Analyses of OXLUMO® (lumasiran) ILLUMINATE-A Results at the National Kidney Foundation Virtual Spring Clinical Meetings
Published: 2021-04-10 (Crawled : 20:20) - alnylam.com
ALNY | News | $145.045 -0.19% -0.19% 400K twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
results kidney
Oncocyte Presents New Data at 2021 American Association for Cancer Research Annual Meeting Demonstrating Potential for Pan-Cancer Utility of DetermaIO™
Published: 2021-04-10 (Crawled : 20:20) - globenewswire.com
OCX J | $2.52 -2.7% -2.78% 37K twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
potential cancer research
PMV Pharma Presents Late-Breaking Preclinical Data on Lead Product Candidate PC14586 at the American Association for Cancer Research Annual Meeting 2021
Published: 2021-04-10 (Crawled : 20:20) - globenewswire.com
PMVP | $1.62 0.62% 0.62% 460K twitter stocktwits trandingview |
Commercial Services
 | Email alert Add to watchlist
cancer research preclinical pre-clinical
C4 Therapeutics Presents Preclinical Data on CFT7455, a Novel IKZF1/3 Degrader for the Treatment of Hematologic Malignancies, at the AACR Annual Meeting 2021
Published: 2021-04-10 (Crawled : 20:20) - globenewswire.com
CCCC | $6.91 0.58% 0.58% 1.1M twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
treatment preclinical pre-clinical
Blueprint Medicines Presents Preclinical Data Highlighting Broad Precision Therapy Research Pipeline at AACR Annual Meeting 2021
Published: 2021-04-10 (Crawled : 16:20) - prnewswire.com
BPMC | News | $88.9 0.59% 0.58% 730K twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
therapy research preclinical pre-clinical
ESSA Pharma Presents Preclinical Data Supporting the Therapeutic Potential of EPI-7386 at the 2021 American Association of Cancer Research (AACR) Annual Meeting
Published: 2021-04-10 (Crawled : 16:20) - prnewswire.com
EPIX | $6.67 -5.66% -6.0% 36K twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
potential cancer research preclinical pre-clinical
Synlogic Presents Data from SYNB1891 Phase 1 Trial at American Association for Cancer Research (AACR) Annual Meeting
Published: 2021-04-10 (Crawled : 16:20) - prnewswire.com
SYBX | $1.74 -1.7% -1.72% 70K twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
phase 1 cancer research trial phase 3 phase 2
Kronos Bio Presents Preclinical Data for Oral CDK9 Inhibitor KB-0742 Demonstrating Sustained Inhibition of Tumor Growth in Multiple Cancers at AACR Annual Meeting 2021
Published: 2021-04-10 (Crawled : 16:20) - globenewswire.com
KRON | $1.01 -2.89% -2.97% 210K twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
cancer growth preclinical pre-clinical
MacroGenics Announces Presentations at the 2021 AACR Annual Meeting
Published: 2021-04-10 (Crawled : 16:20) - globenewswire.com
MGNX | $16.08 -0.12% -0.12% 590K twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
presentation
iTeos Therapeutics Announces New Preliminary Data Indicating Clinical Activity with its Anti-TIGIT Antibody, EOS-448, at the AACR Annual Meeting 2021
Published: 2021-04-10 (Crawled : 16:20) - globenewswire.com
ITOS | $10.335 -3.23% -3.34% 210K twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
antibody
Harpoon Therapeutics Announces Data from Poster Presentations at the AACR Annual Meeting 2021
Published: 2021-04-10 (Crawled : 16:20) - globenewswire.com
HARP | $23.01 0.07% 6.6M twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
presentation
NextCure Presents Preclinical Data for NC762 at American Association for Cancer Research (AACR) Annual Meeting 2021
Published: 2021-04-10 (Crawled : 16:20) - globenewswire.com
NXTC | $1.57 3.97% 3.82% 39K twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
cancer research preclinical pre-clinical
Genocea to Present Novel Preclinical Inhibigen™ Data at AACR Annual Meeting 2021
Published: 2021-04-10 (Crawled : 16:20) - globenewswire.com
GNCA | $0.051 twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
preclinical pre-clinical
NuCana Announces Five Poster Presentations at the American Association for Cancer Research (AACR) Annual Meeting 2021
Published: 2021-04-10 (Crawled : 16:20) - globenewswire.com
NCNA | $4.05 2.02% 1.98% 87K twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
presentation cancer research
Advaxis Presents Translational Biomarker Data from Ongoing ADXS-503 Phase 1/2 Lung Cancer Trial at the American Associated for Cancer Research (AACR) 2021 Annual Meeting
Published: 2021-04-10 (Crawled : 16:20) - globenewswire.com
ADXS | $0.6455 12.48% 2.3K twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
lung cancer ongoing phase 1 cancer research trial phase 3 phase 2 biomarkers
Jounce Therapeutics Presents Preclinical Data from JTX-8064/LILRB2 Program at the 2021 American Association for Cancer Research (AACR) Virtual Annual Meeting
Published: 2021-04-10 (Crawled : 16:20) - globenewswire.com
JNCE | $1.88 -2.59% -1.85% 0 twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
GILD | News | $66.16 -1.15% -1.16% 6.4M twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
cancer research preclinical pre-clinical
Vincerx Pharma Presents Preclinical Data on VIP236, its Lead Small Molecule Drug Conjugate, at the American Association for Cancer Research Annual Meeting 2021
Published: 2021-04-10 (Crawled : 16:20) - globenewswire.com
VINC | $0.8967 -5.63% -5.97% 530K twitter stocktwits trandingview |
| Email alert Add to watchlist
cancer drug research preclinical pre-clinical
TCR² Highlights Gavo-cel Translational Data and Emerging Solid Tumor Pipeline Preclinical Data at AACR Annual Meeting
Published: 2021-04-10 (Crawled : 16:20) - globenewswire.com
TCRR 4 | $1.48 3.38% 3.9M twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
solid tumors preclinical cel pre-clinical
Mersana Therapeutics Presents Preclinical Data Highlighting Potential of XMT-2056 and XMT-1660 in Three Posters at Virtual 2021 AACR Annual Meeting
Published: 2021-04-10 (Crawled : 16:20) - globenewswire.com
MRSN | $3.34 -5.11% -5.39% 1.3M twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
potential preclinical pre-clinical
Gainers vs Losers
64% 36%

Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M twitter stocktwits trandingview |
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M twitter stocktwits trandingview |
Commercial Services
INVO | $1.555 104.6% 51.13% 5M twitter stocktwits trandingview |
Health Technology
ISPC | $0.437 105.16% 49.53% 37M twitter stocktwits trandingview |
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M twitter stocktwits trandingview |

OST | $0.499 21.38% 45.26% 1.9M twitter stocktwits trandingview |

XPON | News | $3.1 60.62% 37.74% 17M twitter stocktwits trandingview |

TIRX | $0.7 44.39% 30.74% 58M twitter stocktwits trandingview |

BNTC | News | $6.92 44.17% 30.64% 3.5M twitter stocktwits trandingview |
Health Technology
GGE | $0.035 19.86% 29.3% 64M twitter stocktwits trandingview |

Your saved searches
Save your searches and get alerts when important news are released.